Heights Capital Management’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-25,880
Closed -$3.11M – 94
2020
Q2
$3.11M Buy
+25,880
New +$3.65M 1.15% 22

Other funds holding DNTH

Heights Capital Management's DNTH Position: Q3 2020 in Review

Heights Capital Management sold out of Dianthus Therapeutics (DNTH) in Q3 2020, closing a stake of 25,880 shares — an estimated $3.11M sold.

Heights Capital Management first reported a position in DNTH in Q2 2020 and held it in 1 quarter. The position peaked at $3.11M in Q2 2020. 94 funds tracked by Wall St. Rank hold DNTH as of Q3 2020.

  • Heights Capital Management reported no remaining Dianthus Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Heights Capital Management sold 25,880 Dianthus Therapeutics shares in Q3 2020, an estimated $3.11M.
  • Heights Capital Management first reported a position in Dianthus Therapeutics in Q2 2020 and held it in 1 quarter.
  • Heights Capital Management's Dianthus Therapeutics position peaked at $3.11M in Q2 2020.
  • 94 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2020.

Based on Heights Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.